Doray Pharma (301075.SZ) released the third quarter report for the year 2024, during the reporting period the company achieved revenue...
Smart Finance APP News, Doray Pharma (301075.SZ) released the third quarter report for the year 2024, during the reporting period the company achieved revenue of 0.201 billion yuan, a decrease of 18.57% year-on-year; net loss attributable to shareholders of the listed company was 17.0787 million yuan; net loss after deducting non-recurring gains and losses attributable to shareholders of the listed company was 19.6861 million yuan; basic loss per share was 0.21 yuan/share.